M ONDAY, Dec. 16, 2024 (HealthDay News) -- High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients ...
The primary outcome of endotracheal intubation or death within 7 days occurred in 39% in the high-flow nasal oxygen group vs 38% in the noninvasive ventilation group overall. Israel S. Maia, M.D., ...
MONDAY, Dec. 16, 2024 (HealthDay News) -- High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients with ...